Bionik Laboratories Corp. (BNKL) Financial Statements (2024 and earlier)

Company Profile

Business Address 80 COOLIDGE HILL ROAD
WATERTOWN, MA 02472
State of Incorp. DE
Fiscal Year End March 31
Industry (SIC) 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
12/31/2021
Q3
9/30/2021
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments6853981,329 3,3704,775
Cash and cash equivalents6853981,329 3,3704,775
Receivables337581119 13071
Inventory, net of allowances, customer advances and progress billings1,1441,3511,419 929789
Inventory1,1441,3511,419 929789
Prepaid expense9099031,056 1,4921,549
Total current assets:3,0753,2333,923 5,9217,184
Noncurrent Assets
Operating lease, right-of-use asset260265    
Property, plant and equipment20618980 5958
Intangible assets, net (including goodwill)135136   5,220
Goodwill100100   4,283
Intangible assets, net (excluding goodwill)3536   937
Other noncurrent assets98    
Total noncurrent assets:61059780 595,278
TOTAL ASSETS:3,6853,8304,003 5,98012,462
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities1,6741,7361,620 1,1151,158
Employee-related liabilities178174  
Accounts payable381352427 181378
Accrued liabilities1,2931,2071,019 933780
Deferred revenue397453247 299195
Debt     8,7408,492
Other undisclosed current liabilities21(158)(174)   
Total current liabilities:2,0922,0321,692 10,1549,844
Noncurrent Liabilities
Long-term debt and lease obligation1,6011,017503   
Long-term debt, excluding current maturities1,601771503   
Liabilities, other than long-term debt514258211 268280
Deferred revenue274258211 268280
Operating lease, liability240246    
Total noncurrent liabilities:2,1151,275714 268280
Total liabilities:4,2073,3072,406 10,42210,125
Equity
Equity, attributable to parent(522)5231,597 (4,442)2,338
Common stock777 66
Additional paid in capital98,43398,40298,347 89,22189,017
Accumulated other comprehensive income303029 2928
Accumulated deficit(98,992)(97,916)(96,786) (93,697)(86,713)
Total equity:(522)5231,597 (4,442)2,338
TOTAL LIABILITIES AND EQUITY:3,6853,8304,003 5,98012,462

Income Statement (P&L) ($ in thousands)

3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
12/31/2021
Q3
9/30/2021
Q2
Revenues575486243 183228
Cost of revenue(305)(189)(75) (50)(81)
Gross profit:271298168 133147
Operating expenses(1,314)(1,409)(1,541) (6,861)(1,189)
Operating income (loss):(1,043)(1,111)(1,373) (6,728)(1,042)
Nonoperating income (expense)(33)(18)(11) (255)(226)
Other nonoperating expense  (1)(11) (255)(226)
Interest and debt expense(30)(17)(5) (249)(225)
Income (loss) from continuing operations before equity method investments, income taxes:(1,107)(1,147)(1,389) (7,233)(1,493)
Other undisclosed income from continuing operations before income taxes      
Income (loss) from continuing operations:(1,107)(1,147)(1,389) (7,233)(1,493)
Loss before gain (loss) on sale of properties:(1,147)(1,389)(7,233)(1,493)
Other undisclosed net income  5   
Net income (loss):(1,107)(1,147)(1,384) (7,233)(1,493)
Other undisclosed net income attributable to parent 3017  249225
Net income (loss) available to common stockholders, diluted:(1,076)(1,129)(1,384) (6,984)(1,268)

Comprehensive Income ($ in thousands)

3/31/2023
Q4
12/31/2022
Q3
9/30/2022
Q2
6/30/2022
Q1
3/31/2022
Q4
12/31/2021
Q3
9/30/2021
Q2
Net income (loss):(1,107)(1,147)(1,384) (7,233)(1,493)
Comprehensive income (loss):(1,107)(1,147)(1,384) (7,233)(1,493)
Other undisclosed comprehensive income, net of tax, attributable to parent31181 250219
Comprehensive income (loss), net of tax, attributable to parent:(1,076)(1,129)(1,383) (6,983)(1,274)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: